Drug Shortage Report for SYNAREL

Last updated on 2023-01-23 History
Report ID 175176
Drug Identification Number 02188783
Brand name SYNAREL
Common or Proper name SYNAREL
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) NAFARELIN
Strength(s) 200MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration NASAL NASAL
Packaging size 8ML
ATC code H01CA
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-11-22
Actual start date 2022-11-22
Estimated end date 2023-04-21
Actual end date
Shortage status Actual shortage
Updated date 2023-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-01-23 French Compare
v4 2023-01-23 English Compare
v3 2022-11-23 English Compare
v2 2022-11-17 French Compare
v1 2022-11-17 English Compare

Showing 1 to 5 of 5